|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/705 | |
| C07K 16/18 | |||
| A61K 38/16 | |||
| A61K 38/17 | |||
| A61K 38/45 | |||
| A61K 39/395 |
| (11) | Number of the document | 3233902 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15871120.0 |
| Date of filing the European patent application | 2015-12-17 | |
| (97) | Date of publication of the European application | 2017-10-25 |
| (45) | Date of publication and mention of the grant of the patent | 2020-09-09 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2015/066498 |
| Date | 2015-12-17 |
| (87) | Number | WO 2016/100738 |
| Date | 2016-06-23 |
| (30) | Number | Date | Country code |
| 201462093937 P | 2014-12-18 | US |
| (72) |
MIAO, Yu Rebecca, US
TABIBIAZAR, Raymond, US
GIACCIA, Amato J., US
KARIOLIS, Mihalis, US
|
| (73) |
Aravive Biologics, Inc.,
LyondellBasell Tower 1221 McKinney, Suite 3200, Houston, TX 77010,
US
The Board of Trustees of the Leland Stanford Junior University, Office of the General Counsel Building 170, Third Floor, Main Quad P.O. Box 20386, Stanford, CA 94305-2038, US |
| (54) | ANTIFIBROTIC ACTIVITY OF GAS6 INHIBITOR |
| ANTIFIBROTIC ACTIVITY OF GAS6 INHIBITOR |